AAAAAA

   
Results: 1-8 |
Results: 8
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: Results of an Italian cooperative study
Authors: Boccardo, F Rubagotti, A Amoroso, D Mesiti, M Romeo, D Caroti, C Farris, A Cruciani, G Villa, E Schieppati, G Mustacchi, G
Citation: F. Boccardo et al., Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: Results of an Italian cooperative study, J CL ONCOL, 19(22), 2001, pp. 4209-4215
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial
Authors: Ballestrero, A Rubagotti, A Stura, P Ferrando, F Amoroso, D Rinaldini, M Sismondi, P Genta, F Mesiti, M Brema, F Patrone, F Boccardo, F
Citation: A. Ballestrero et al., Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial, ONCOL-BASEL, 60(3), 2001, pp. 221-227
Management of breast cancer: Is there a role for somatostatin and its analogs?
Authors: Boccardo, F Amoroso, D
Citation: F. Boccardo et D. Amoroso, Management of breast cancer: Is there a role for somatostatin and its analogs?, CHEMOTHERA, 47, 2001, pp. 62-77
The life, death, and ROMP activity of ruthenium complexes containing the basic, chelating diphosphine bis(dicyclohexyl)-1,4-phosphinobutane
Authors: Amoroso, D Yap, GPA Fogg, DE
Citation: D. Amoroso et al., The life, death, and ROMP activity of ruthenium complexes containing the basic, chelating diphosphine bis(dicyclohexyl)-1,4-phosphinobutane, CAN J CHEM, 79(5), 2001, pp. 958-963
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial
Authors: Boccardo, F Rubagotti, A Amoroso, D Mesiti, M Romeo, D Sismondi, P Giai, M Genta, F Pacini, P Distante, V Bolognesi, A Aldrighetii, D Farris, A
Citation: F. Boccardo et al., Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial, J CL ONCOL, 18(14), 2000, pp. 2718-2727
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin
Authors: Ballestrero, A Ferrando, F Garuti, A Gonella, R Stura, P Sessarego, M Amoroso, D Boccardo, F Patrone, F
Citation: A. Ballestrero et al., Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin, ONCOL-BASEL, 59(1), 2000, pp. 7-13
Ring-opening metathesis polymerization via ruthenium complexes of chelating diphosphines
Authors: Amoroso, D Fogg, DE
Citation: D. Amoroso et De. Fogg, Ring-opening metathesis polymerization via ruthenium complexes of chelating diphosphines, MACROMOLEC, 33(8), 2000, pp. 2815-2818
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients
Authors: Boccardo, F Rubagotti, A Amoroso, D Agostara, B Amadori, D Gallo, L Iacobelli, S Massidda, B Mesiti, M Pacini, P Tomao, S Paganuzzi, M Marroni, P
Citation: F. Boccardo et al., Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients, CANC CHEMOT, 43(6), 1999, pp. 461-466
Risultati: 1-8 |